TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 74 filers reported holding TRICIDA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,336,000 | +26.6% | 700,000 | +366.7% | 2.06% | +36.1% |
| Q1 2019 | $5,793,000 | -1.7% | 150,000 | -40.0% | 1.51% | -29.3% |
| Q4 2018 | $5,895,000 | -22.8% | 250,000 | 0.0% | 2.14% | +31.7% |
| Q3 2018 | $7,638,000 | +37.3% | 250,000 | +34.4% | 1.62% | -0.8% |
| Q2 2018 | $5,562,000 | – | 186,019 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |